GETTING MY API IN PHARMACEUTICAL MANUFACTURING TO WORK

“The existing scenario has exposed some structural weaknesses inside the EU’s medicines supply chain as well as a high dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She advisable that supply chain concerns be tackled within an EU pharmaceutical technique predicted to be released by the